The cost of cure

Lancet Haematol. 2018 Nov;5(11):e504-e505. doi: 10.1016/S2352-3026(18)30070-X. Epub 2018 Jun 12.

Authors

Kjeld Schmiegelow¹, Thomas Leth Frandsen²

Affiliations

¹ Department of Paediatrics and Adolescent Medicine, Juliane Marie Centre, Righospitalet University Hospital, Copenhagen 2100, Denmark; Institute of Clinical Medicine, Faculty of Medicine, University of Copenhagen, Copenhagen, Denmark. Electronic address: kjeld.schmiegelow@regionh.dk.
² Department of Paediatrics and Adolescent Medicine, Juliane Marie Centre, Righospitalet University Hospital, Copenhagen 2100, Denmark.

PMID: 29907548
DOI: 10.1016/S2352-3026(18)30070-X

No abstract available

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / economics
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Combined Modality Therapy / economics
Costs and Cost Analysis*
Hematologic Neoplasms / mortality
Hematologic Neoplasms / therapy*
Hematopoietic Stem Cell Transplantation*
Humans
Molecular Targeted Therapy
Patient Outcome Assessment
Survival Analysis